Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface

REFERENCES

• Maus M. Basic eyelid anatomy. In: Albert DM, Jakobiec FA eds. Principles and Practice of Ophthalmology Clinical Practice. Philadelphia, Pennsylvannia: W B Saunders Company, 1994. pp 1689–1692.
   Google Scholar
• Remington LA. Ocular adnexa and lacrimal system. In. Clinical Anatomy of the Visual System. Newton, Massachusetts: Butterworth‐Heinemann, 1998. p 137–140.
   Google Scholar
• Draelos ZK. Eye cosmetics. Dermatol Clin 1991; 9: 1–7.
   Web of Science ®Google Scholar
• Jones D. Enhanced eyelashes: prescription and over‐the‐counter options. Aesthetic Plast Surg 2011; 35: 116–121.
   Web of Science ®Google Scholar
• Statista. Statistics and facts on the cosmetic industry. Available at: http://www.statista.com/topics/1008/cosmetics‐industry. [Accessed 6 February 2016].
   Google Scholar
• Statista. Mascara sales in the US in 2014. Available at: http://www.statista.com/statistics/435778/mascara‐sales‐in‐the‐us‐by‐channel. [Accessed 6 February 2016].
   Google Scholar
• Paus R, Burgoa I, Platt CI et al. Biology of the eyelash hair follicle: an enigma in plain sight. Br J Dermatol 2016; 174: 741–752.
   Web of Science ®Google Scholar
• Kumar A, Karthikeyan K. Madarosis: a marker of many maladies. Intern J Trichol 2012; 4: 3–18.
   PubMedGoogle Scholar
• Trueb RM. Chemotherapy‐induced alopecia. Semin Cutan Med Surg 2009; 28: 11–14.
   PubMed Web of Science ®Google Scholar
• Ahluwalia GS. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy‐induced eyelash loss. J Invest Dermatol Symp Proc 2013; 16: S73–S76.
   PubMedGoogle Scholar
• Duke‐elder S, Wybar K. The eyelids. In: Duke‐elder S ed. System of Ophthalmology. The Anatomy of the Visual System. St. Louis: The CV Mosby Company, 1961. p 524.
   Google Scholar
• Na JI, Kwon OS, Kim BJ et al. Ethnic characteristics of eyelashes: a comparative analysis in Asian and Caucasian females. Br J Dermatol 2006; 155: 1170–1176.
   PubMed Web of Science ®Google Scholar
• Cohen JL. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost‐induced eyelash growth. Dermatol Surg 2010; 36: 1361–1371.
   PubMed Web of Science ®Google Scholar
• Johnstone MA, Albert DM. Prostaglandin‐induced hair growth. Surv Ophthalmol 2002; 47 (Suppl 1): S185–S202.
   PubMed Web of Science ®Google Scholar
• Mann D, Raymer M. Catch up on cosmetic enhancements. Rev Optom 2010; 147: 82–86.
   Google Scholar
• Shaikh MY, Bodla AA. Hypertrichosis of the eyelashes from prostaglandin analog use: a blessing or a bother to the patient? J Ocul Pharmacol Ther 2006; 22: 76–77.
   PubMed Web of Science ®Google Scholar
• Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997; 124: 544–547.
   PubMed Web of Science ®Google Scholar
• Hart J, Shafranov G. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost. Am J Ophthalmol 2004; 137: 756–757.
   Web of Science ®Google Scholar
• Fagien S. Management of hypotrichosis of the eyelashes: Focus on bimatoprost. Clin Cosmet Invest Dermatol 2010; 3: 39–48.
   PubMedGoogle Scholar
• Hempstead N, Hempstead RW. Unilateral trichomegaly induced by bimatoprost ophthalmic solution. J Drugs Dermatol 2004; 3: 571–572.
   Google Scholar
• Herane MI, Urbina F. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost. J Eur Acad Dermatol Venereol 2004; 18: 644–645.
   Web of Science ®Google Scholar
• Flaharty PM, Flaharty KK, Gorman L. Latisse (bimatoprost) for enhancement of eyelashes. Insight 2014; 39: 24–26.
   Google Scholar
• Allergan. Latisse Product Monograph, 2010.
   Google Scholar
• Allergan. Latisse (bimatoprost ophthalmic solution) 0.03% Highlights of prescribing information, 2009.
   Google Scholar
• Woodson SA. Latisse: empirical discovery yields treatment for sparse eyelashes. Nurs Womens Health 2009; 13: 243–248.
   Google Scholar
• Caffery BE, Josephson JE. Complications of lens care solutions. In: Silbert JA ed. Anterior Segment Complications of Contact Lens Wear. New York: Churchill Livingstone, 1994. pp 149–150.
   Google Scholar
• Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther 2001; 18: 205–215.
   PubMed Web of Science ®Google Scholar
• Noecker R, Miller KV. Benzalkonium chloride in glaucoma medications. Ocul Surf 2011; 9: 159–162.
   PubMed Web of Science ®Google Scholar
• Silbert JA. Ocular inflammation and contact lens wear. In: Tomlinson A ed. Complications of Contact Lens Wear. St. Louis, Missouri, USA: Mosby Yearbook, 1992. pp 221–235.
   Google Scholar
• Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol 2008; 86: 716–726.
   PubMed Web of Science ®Google Scholar
• Horsley MB, Kahook MY. Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients. Clin Ophthalmol 2009; 3: 291–295.
   PubMedGoogle Scholar
• Yee RW, Norcom EG, Zhao XC. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system. Adv Ther 2006; 23: 511–519.
   PubMed Web of Science ®Google Scholar
• Kahook MY, Noecker RJ. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative‐free artificial tears. Cornea 2008; 27: 339–343.
   PubMed Web of Science ®Google Scholar
• Lopes JF, Hubatsch DA, Amaris P. Effect of benzalkonium chloride‐free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open‐label study. BMC Ophthalmol 2015; 15: 166.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118: 615–621.
   PubMed Web of Science ®Google Scholar
• IER Grading Scale. In. Sydney, Australia: Institute of Eye Research, 2007.
   Google Scholar
• Benelli U, Nardi M, Posarelli C et al. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Contact Lens Anterior Eye 2010; 33: 61–67.
   PubMed Web of Science ®Google Scholar
• Schulze MM, Hutchings N, Simpson TL. The perceived bulbar redness of clinical grading scales. Optom Vis Sci 2009; 86: E1250–E1258.
   Web of Science ®Google Scholar
• Terry RL, Schnider CM, Holden BA et al. CCLRU standards for success of daily and extended wear contact lenses. Optom Vis Sci 1993; 70: 234–243.
   PubMed Web of Science ®Google Scholar
• Efron N. Grading scales for contact lens complications. Ophthalmic Physiol Opt 1998; 18: 182–186.
   PubMed Web of Science ®Google Scholar
• Sorbara L, Simpson T, Duench S et al. Comparison of an objective method of measuring bulbar redness to the use of traditional grading scales. Contact Lens Anterior Eye 2007; 30: 53–59.
   Google Scholar
• Schulze MM, Hutchings N, Simpson TL. Grading bulbar redness using cross‐calibrated clinical grading scales. Invest Ophthalmol Vis Sci 2011; 52: 5812–5817.
   PubMed Web of Science ®Google Scholar
• Downie LE, Keller PR, Vingrys AJ. Assessing ocular bulbar redness: a comparison of methods. Ophthalmic Physiol Opt 2016; 36: 132–139.
   Web of Science ®Google Scholar
• Vucea V, Bernard PJ, Sauvageau P et al. Blood oxygenation measurements by multichannel reflectometry on the venous and arterial structures of the retina. Appl Opt 2011; 50: 5185–5191.
   Web of Science ®Google Scholar
• Diaconu V. Multichannel spectroreflectometry: a non‐invasive method for assessment of on‐line hemoglobin derivatives. Appl Opt 2009; 48: D52–61.
   Web of Science ®Google Scholar
• Shevell SK. The Science of Color. 2nd edn: Washington, DC, USA: Optical Society of America, 2003.
   Google Scholar
• Priluck JC, Fu S. Latisse‐induced periocular skin hyperpigmentation. Arch Ophthalmol 2010; 128: 792–793.
   Google Scholar
• De saint Jean M, Brignole F, Bringuier AF et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999; 40: 619–630.
   PubMed Web of Science ®Google Scholar
• Niimi J, Tan B, Chang J et al. Diurnal pattern of tear osmolarity and its relationship to corneal thickness and deswelling. Cornea 2013; 32: 1305–1310.
   PubMed Web of Science ®Google Scholar
• Law SK. Bimatoprost in the treatment of eyelash hypotrichosis. Clin Ophthalmol 2010; 4: 349–358.
   PubMedGoogle Scholar
• Sit AJ, Nau CB, Mclaren JW et al. Circadian variation of aqueous dynamics in young healthy adults. Invest Ophthalmol Vis Sci 2008; 49: 1473–1479.
   PubMed Web of Science ®Google Scholar
• Wilensky JT. Diurnal variations in intraocular pressure. Trans Am Ophthalmol Soc 1991; 89: 757–790.
   PubMedGoogle Scholar
• David R, Zangwill L, Briscoe D et al. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol 1992; 76: 280–283.
   PubMed Web of Science ®Google Scholar
• Wilson LA, Julian AJ, Ahearn DG. The survival and growth of microorganisms in mascara during use. Am J Ophthalmol 1975; 79: 596–601.
   PubMed Web of Science ®Google Scholar
• Kadri R, Achar A, Tantry TP et al. Mascara induced milphosis, an etiological evaluation. Intern J Trichol 2013; 5: 144–147.
   Google Scholar
• Fukami K, Inoue T, Kawai T et al. Internal structure changes of eyelash induced by eye makeup. J Cosmet Sci 2014; 65: 217–224.
   Web of Science ®Google Scholar
• Avitzur O. Eyelash extensions can pose health risks. Consumer Report, ABC News USA, 2013.
   Google Scholar